###begin article-title 0
###xml 103 107 <span type="species:ncbi:10090">Mice</span>
MEF2C Silencing Attenuates Load-Induced Left Ventricular Hypertrophy by Modulating mTOR/S6K Pathway in Mice
###end article-title 0
###begin p 1
Conceived and designed the experiments: AHMP CFMZC ACC ILC KGF. Performed the experiments: AHMP CFMZC ACC THT SAR CCJ MCG VDBP JRMS. Analyzed the data: AHMP CFMZC ACC THT SAR CCJ MCG VDBP JRMS KGF. Contributed reagents/materials/analysis tools: ILC. Wrote the paper: AHMP CFMZC KGF.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
The activation of the members of the myocyte enhancer factor-2 family (MEF2A, B, C and D) of transcription factors promotes cardiac hypertrophy and failure. However, the role of its individual components in the pathogenesis of cardiac hypertrophy remains unclear.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 128 132 <span type="species:ncbi:10090">mice</span>
###xml 325 329 <span type="species:ncbi:10090">mice</span>
###xml 793 797 <span type="species:ncbi:10090">mice</span>
In this study, we investigated whether MEF2C plays a role in mediating the left ventricular hypertrophy by pressure overload in mice. The knockdown of myocardial MEF2C induced by specific small interfering RNA (siRNA) has been shown to attenuate hypertrophy, interstitial fibrosis and the rise of ANP levels in aortic banded mice. We detected that the depletion of MEF2C also results in lowered levels of both PGC-1alpha and mitochondrial DNA in the overloaded left ventricle, associated with enhanced AMP:ATP ratio. Additionally, MEF2C depletion was accompanied by defective activation of S6K in response to pressure overload. Treatment with the amino acid leucine stimulated S6K and suppressed the attenuation of left ventricular hypertrophy and fibrosis in the aforementioned aortic banded mice.
###end p 5
###begin title 6
Conclusion/Significance
###end title 6
###begin p 7
These findings represent new evidences that MEF2C depletion attenuates the hypertrophic responses to mechanical stress and highlight the potential of MEF2C to be a target for new therapies to cardiac hypertrophy and failure.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 200 203 200 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Katz1">[1]</xref>
###xml 205 208 205 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Opie1">[2]</xref>
###xml 210 213 210 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Vakili1">[3]</xref>
###xml 504 507 504 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Diwan1">[4]</xref>
###xml 729 732 729 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Chien1">[5]</xref>
###xml 734 737 734 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Heineke1">[6]</xref>
###xml 739 742 739 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Dorn1">[7]</xref>
Hypertrophy is a common feature of many forms of heart disease. While initially an adaptive response to increased workload and injury, in the long term cardiac hypertrophy predisposes to heart failure[1], [2], [3]. At the cellular level, myocardial hypertrophy is characterized by distinct accumulation of myofibrillar proteins and organelles in cardiomyocytes, while the development of heart failure is accompanied by degeneration and loss of hypertrophic cardiomyocytes as well as interstitial fibrosis[4]. In a current view, the hypertrophy and degeneration of cardiomyocytes represent a continuum governed by patterns of beneficial and adverse signaling triggered by stimuli such as mechanical stress and neurohumoral factors[5], [6], [7].
###end p 9
###begin p 10
###xml 87 114 87 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myocyte enhancer factors-2,</italic>
###xml 229 232 229 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Xu1">[8]</xref>
###xml 234 237 234 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-vanOort1">[9]</xref>
###xml 239 243 239 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Kim1">[10]</xref>
###xml 409 413 409 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Molkentin1">[11]</xref>
###xml 415 419 415 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Nadruz1">[12]</xref>
###xml 421 425 421 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Nadruz2">[13]</xref>
###xml 663 666 663 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Xu1">[8]</xref>
###xml 866 869 866 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Xu1">[8]</xref>
###xml 871 874 871 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-vanOort1">[9]</xref>
###xml 876 880 876 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Kim1">[10]</xref>
###xml 984 988 984 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Hannenhalli1">[14]</xref>
###xml 1196 1199 1196 1199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-vanOort1">[9]</xref>
###xml 1477 1481 1477 1481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Kim1">[10]</xref>
###xml 1850 1854 1850 1854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Lin1">[15]</xref>
###xml 1856 1860 1856 1860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Bi1">[16]</xref>
###xml 1862 1866 1862 1866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Naya1">[17]</xref>
###xml 721 725 <span type="species:ncbi:10090">mice</span>
###xml 965 970 <span type="species:ncbi:9606">human</span>
###xml 1229 1233 <span type="species:ncbi:10090">mice</span>
###xml 1372 1376 <span type="species:ncbi:10090">mice</span>
Among the intracellular pathways that integrate mechanical and hormonal signals, MEF2 (myocyte enhancer factors-2, members A to D) transcription factors play prominent roles in the regulation of cardiac hypertrophy and remodeling[8], [9], [10]. In this context, many studies have shown that overall MEF2 DNA-binding activity is enhanced in cardiomyocytes in response to biomechanical and neurohormonal stimuli[11], [12], [13]. Overexpression of MEF2A or MEF2C in cultured cardiomyocytes induces sarcomere degeneration and cardiomyocytes elongation, suggesting that activation of these members may compose signaling pathways responsible for pathologic hypertrophy [8]. Accordingly, forced expressions of MEF2A, C and D in mice heart were demonstrated to be sufficient to drive intolerance to pressure overload, ventricular chamber dilation and contractile dysfunction[8], [9], [10]. There is also evidence associating MEF2 transcription factors with common forms of human heart failure[14]. Furthermore, the transgenic expression of negative dominants of MEF2 was shown to prevent chamber dilation and mechanical dysfunction, with minor effects on cardiac growth in calcineurin-induced hypertrophy[9]. Recent studies performed in mice with dominant-negative MEF2D suggested that this factor is an important mediator of the pathologic left ventricular hypertrophy, as these mice displayed no cardiac hypertrophy, fibrosis or fetal gene activation in response to pressure overload[10]. Altogether, these evidences support the idea that MEF2 factors mediate the effects of detrimental signaling pathways in response to hypertrophic stimuli. Nevertheless, the role of each specific MEF2 member, such as MEF2A or MEF2C, in cardiac hypertrophy remains unclear mainly because of the lethal cardiac phenotypes resulting from genetic deletions of these members[15], [16], [17].
###end p 10
###begin p 11
###xml 153 160 153 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 138 143 <span type="species:ncbi:10090">mouse</span>
###xml 258 262 <span type="species:ncbi:10090">mice</span>
To define the potential function of MEF2C in the cardiac responses to pressure overload we conceived a strategy to deplete this factor in mouse heart by in vivo delivery of small interfering (si)RNA. Left ventricular hypertrophy induced by aortic banding in mice was used as a model system in this study.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
Optimization of Myocardial MEF2C Silencing by siRNA
###end title 13
###begin p 14
###xml 261 265 261 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Marin1">[18]</xref>
###xml 487 496 487 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008472-g001">Figure 1A</xref>
###xml 577 588 577 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008472-g001">Figure 1B-D</xref>
###xml 1085 1097 1085 1097 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008472-g001">Figure 1E, F</xref>
###xml 124 127 <span type="species:ncbi:10116">Rat</span>
As an initial approach, experiments were set to test the efficacy of siMEF2C to knockdown MEF2C in cultured NRVMs (Neonatal Rat Ventricular Myocytes). Transfection efficiency of siRNA in this model system was previously assessed with fluorescent oligonucleotide[18] and was demonstrated to range around 80% in respect to cells treated with the irrelevant siGFP (Green Fluorescent Protein). Transfection of siMEF2C (300 ng/ml) reduced the MEF2C transcripts in NRVMs by approximately 80% (Figure 1A). siMEF2C had no influence in the amounts of MEF2A, MEF2B or MEF2D transcripts (Figure 1B-D). Quantitative PCRs were normalized by GAPDH (Glyceraldehyde 3-phosphate dehydrogenase). An antibody that was specific to MEF2C recognized a protein with a molecular weight close to 55KDa while specific antibody to MEF2A recognized a protein at about 72KDa in the extracts of NRVMs. Western blot analysis indicated that MEF2C was reduced in the order of 75%, while no change could be observed in the expression of MEF2A in cells treated with siMEF2C, in comparison with cells treated with siGFP (Figure 1E, F). Immunoblottings with anti-GAPDH antibody were used as control.
###end p 14
###begin title 15
MEF2C silencing in NRVMs culture.
###end title 15
###begin p 16
###xml 0 3 0 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(A)</bold>
###xml 156 159 156 159 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(B)</bold>
###xml 205 208 205 208 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(C)</bold>
###xml 254 257 254 257 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(D)</bold>
###xml 350 353 350 353 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(F)</bold>
(A) Bar graph shows relative quantity (RQ) of MEF2C in respect to GAPDH transcripts as a percentage of calibrator sample (siGFP) obtained by real time-PCR. (B) Bar graph shows the RQ of MEF2A transcripts. (C) Bar graph shows the RQ of MEF2B transcripts. (D) Bar graph shows the RQ of MEF2D transcripts. (E) MEF2C protein expression (n = 3 cultures). (F), MEF2A protein expression. * p<0.05 vs treatment with siGFP. These data are from 3 NRVMs culture at least.
###end p 16
###begin p 17
###xml 268 272 264 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Clemente1">[19]</xref>
###xml 422 431 414 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008472-g002">Figure 2A</xref>
###xml 575 584 563 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008472-g002">Figure 2B</xref>
###xml 717 728 705 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008472-g002">Figure 2C-F</xref>
###xml 879 891 867 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008472-g002">Figure 2F, G</xref>
###xml 176 180 <span type="species:ncbi:10090">mice</span>
###xml 852 856 <span type="species:ncbi:10090">mice</span>
After the initial characterization in NRVMs, we then searched for an amount of siMEF2C that, when injected systemically via the jugular vein, could deplete myocardial MEF2C in mice left ventricle. We started off with 450 microg/Kg of siMEF2C based on a previous report[19] and observed an expressive reduction, of about 85%, of myocardial MEF2C protein expression 1 day after bolus injections of 900 microg/Kg of siMEF2C (Figure 2A). Injections of siGFP (900 microg/Kg) did not affect MEF2C expression levels in the left ventricle in comparison with phosphate buffer saline (Figure 2B). The treatment with siMEF2C was accompanied by marked reduction of MEF2C transcripts, but not of those from MEF2A, MEF2B or MEF2D (Figure 2C-F), after normalization to GAPDH. Reduction in MEF2C transcripts and protein levels was also demonstrated to occur in banded mice treated with siMEF2C (Figure 2F, G).
###end p 17
###begin title 18
###xml 35 39 <span type="species:ncbi:10090">mice</span>
Optimization of MEF2C silencing in mice left ventricle.
###end title 18
###begin p 19
###xml 0 3 0 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(A)</bold>
###xml 108 111 108 111 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(B)</bold>
###xml 207 210 207 210 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(C)</bold>
###xml 244 247 244 247 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(D)</bold>
###xml 258 261 258 261 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(E)</bold>
###xml 332 335 328 331 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(F)</bold>
###xml 393 396 389 392 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(G)</bold>
###xml 440 443 436 439 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(H)</bold>
###xml 543 546 539 542 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(I)</bold>
###xml 148 152 <span type="species:ncbi:10090">mice</span>
###xml 283 287 <span type="species:ncbi:10090">mice</span>
###xml 357 361 <span type="species:ncbi:10090">mice</span>
###xml 537 541 <span type="species:ncbi:10090">mice</span>
###xml 611 615 <span type="species:ncbi:10090">mice</span>
(A) MEF2C protein expression from assays with increasing amounts of siMEF2C or siGFP, via the jugular vein. (B) Myocardial expression of MEF2C from mice treated with siGFP and phosphate buffer saline (PBS). (C) Relative quantity (RQ) of MEF2C, (D) MEF2A and (E) MEF2B transcripts in mice treated with 30 microg of siMEF2C or siGFP. (F) MEF2D transcripts in mice treated with siMEF2C or siGFP. (G) Bar graphs show RQ of MEF2C transcript and (H) MEF2C protein expression in the left ventricle of aortic banded (TAC) and sham-operated (SO) mice. (I) MEF2C protein expression in adult cardiomyocytes harvested from mice left ventricle 24 hours after siRNA treatment. * p<0.05 vs SOsiGFP; # p<0.05 vs TACsiGFP. At least 6 animals were analyzed in these experiments.
###end p 19
###begin p 20
###xml 334 343 322 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008472-g002">Figure 2H</xref>
Complementary data on the ability of siMEF2C to deplete MEF2C protein levels was obtained by analyzing isolated cardiomyocytes. The expression of MEF2C was reduced in cardiomyocytes harvested from the left ventricle 24 hours after the treatment with siMEF2C to similar levels of myocardial extracts (approximately75%), as depicted in Figure 2H.
###end p 20
###begin p 21
###xml 139 148 139 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008472-g003">Figure 3A</xref>
###xml 257 259 257 259 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 318 320 318 320 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 589 598 589 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008472-g003">Figure 3B</xref>
###xml 661 665 661 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Nadruz1">[12]</xref>
###xml 667 671 667 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Nadruz2">[13]</xref>
###xml 673 677 673 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Marin1">[18]</xref>
###xml 751 760 751 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008472-g003">Figure 3C</xref>
###xml 241 245 <span type="species:ncbi:10090">mice</span>
###xml 398 402 <span type="species:ncbi:10090">mice</span>
We then set to address the time-course of MEF2C reduction in the left ventricle obtained after systemically delivered siMEF2C. As shown in Figure 3A, MEF2C protein expression was reduced by approximately 75% in the left ventricle of control mice up to the 4th day after the administration of siMEF2C. However, by the 7th day after the siMEF2C myocardial MEF2C reached levels comparable to those of mice treated with siGFP and remained unchanged thereafter. Further analysis confirmed similar reductions in MEF2C transcripts in the myocardium over time after the administration of siMEF2C (Figure 3B). Signaling molecules potentially involved in MEF2C activation[12], [13], [18] were also examined to exclude off-target effects of siMEF2C. As shown in Figure 3C, no change was detected in the myocardial levels of FAK (Focal Adhesion Kinase), JNK (c-Jun N-Terminal Kinase) or Shp2 (Src homology region 2, phosphatase 2) after treatment with siMEF2C.
###end p 21
###begin title 22
Effects of siMEF2C in distinct tissues and signaling proteins.
###end title 22
###begin p 23
###xml 0 3 0 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(A)</bold>
###xml 48 51 48 51 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(B)</bold>
###xml 91 94 91 94 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(C)</bold>
###xml 146 149 146 149 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(D)</bold>
###xml 192 196 <span type="species:ncbi:10090">mice</span>
###xml 259 263 <span type="species:ncbi:10090">mice</span>
(A) Time-course of MEF2C protein expression and (B) transcript levels normalized by GAPDH. (C) Myocardial expression of FAK, JNK, SHP2 and GAPDH. (D) Relative quantity of MEF2C transcripts in mice lung and kidney. * p<0.05 vs treatment with siGFP. At least 5 mice were employed for each subgroup.
###end p 23
###begin p 24
###xml 220 229 220 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008472-g003">Figure 3D</xref>
###xml 193 197 <span type="species:ncbi:10090">mice</span>
The consequences of the treatment with siMEF2C in tissues such as lung and kidney were analyzed. We found reductions of MEF2C transcripts in the lung similar as to those of left ventricle from mice treated with siMEF2C (Figure 3D). However, treatment with siMEF2C did not change the amount of MEF2C transcripts in the kidney. Overall, the results establish that siMEF2 administered via jugular vein can silence left ventricle MEF2C protein levels, although it also depletes MEF2C in the lungs.
###end p 24
###begin title 25
###xml 69 73 <span type="species:ncbi:10090">Mice</span>
MEF2C Silencing Attenuates Load-Induced Hypertrophy in Aortic Banded Mice
###end title 25
###begin p 26
###xml 994 1003 994 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008472-g004">Figure 4A</xref>
###xml 1096 1108 1096 1108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008472-g004">Figure 4B, C</xref>
###xml 1225 1232 1225 1232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008472-t001">Table 1</xref>
###xml 1354 1363 1354 1363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008472-g004">Figure 4D</xref>
###xml 1447 1456 1447 1456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008472-g004">Figure 4E</xref>
###xml 165 169 <span type="species:ncbi:10090">mice</span>
###xml 335 339 <span type="species:ncbi:10090">mice</span>
###xml 565 569 <span type="species:ncbi:10090">mice</span>
###xml 1188 1192 <span type="species:ncbi:10090">mice</span>
###xml 1299 1303 <span type="species:ncbi:10090">mice</span>
Next we investigated whether MEF2C silencing affects the load-induced left ventricular hypertrophy. In this set of experiments siMEF2C was intravenously injected in mice via jugular vein one day before sham-operation or aortic banding. We found that blood pressure, heart rate, left ventricular structure and function of sham-operated mice were unaffected by siMEF2C, indicating that depletion of MEF2C does not influence basal cardiac function or structure. Therefore, for the analysis of left ventricle echocardiography and gravimetry we considered sham-operated mice treated with siGFP or siMEF2C as a single control group. Treatment with siGFP did not affect the typical changes of the left ventricle induced by pressure overload (i.e. increases of left ventricle thickness, cardiomyocyte diameter and interstitial fibrosis). Pretreatment with siMEF2C retarded the load-induced left ventricular hypertrophy as assessed by echocardiographic determination of left ventricular wall thickness (Figure 4A). Depletion of MEF2C did not change the left ventricular diameter or fractional shortening (Figure 4B, C). Notably, the systolic gradient across the aortic constriction was similar in mice injected with siGFP or siMEF2C (Table 1). The attenuation of load-induced left ventricular hypertrophy in mice treated with siMEF2C was confirmed by gravimetry (Figure 4D). In addition, siMEF2C attenuated the increases in the diameter of cardiomyocytes (Figure 4E).
###end p 26
###begin title 27
MEF2C silencing prevents load-induced left ventricular hypertrophy.
###end title 27
###begin p 28
###xml 165 168 165 168 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(A)</bold>
###xml 202 205 202 205 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(B)</bold>
###xml 237 240 237 240 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(C)</bold>
###xml 384 387 384 387 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(D)</bold>
###xml 448 451 448 451 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(E)</bold>
###xml 47 51 <span type="species:ncbi:10090">mice</span>
###xml 286 290 <span type="species:ncbi:10090">mice</span>
###xml 583 587 <span type="species:ncbi:10090">mice</span>
Data from sham operated (SO) and aortic banded mice (7 to 15 days after transverse aortic constriction - TAC). Bar graphs indicating the echocardiographic values of (A) posterior wall thickness (LVWT), (B) diastolic diameter (LVEDD) and (C) fractional shortening (FS). The values of SO mice treated with siMEF2C or siGFP did not reach statistical significance, so they were averaged. (D) Bar graphs show the left ventricle mass/body mass ratio and (E) the average cardiomyocytes diameter. * p<0.05 vs SO; # p<0.05 vs TAC 7days siGFP; dagger p<0,05 vs TAC 15 days siGFP. A total of 9 mice were analyzed in each subgroup.
###end p 28
###begin title 29
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice hemodynamics.
###end title 29
###begin p 30
SO. Sham operated; TAC. transverse aorta constricted; SBPa. systolic blood pressure in ascending aorta; SBPf. systolic blood pressure in femoral artery; SGr. systolic gradient; HR. heart rate.
###end p 30
###begin p 31
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 68 72 <span type="species:ncbi:10090">mice</span>
*P<0.05 indicated statistical significance compared to values of SO mice treated whit vehicle.
###end p 31
###begin p 32
###xml 2 3 2 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 69 73 <span type="species:ncbi:10090">mice</span>
# P<0.05 indicated statistical significance compared to values of SO mice treated whith leucine.
###end p 32
###begin p 33
###xml 124 135 124 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008472-g005">Figure 5A&#8211;F</xref>
###xml 222 231 222 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008472-g005">Figure 5G</xref>
###xml 234 243 234 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008472-g005">Figure 5H</xref>
###xml 76 80 <span type="species:ncbi:10090">mice</span>
###xml 195 199 <span type="species:ncbi:10090">mice</span>
###xml 364 368 <span type="species:ncbi:10090">mice</span>
###xml 497 501 <span type="species:ncbi:10090">mice</span>
Representative examples of myocardial samples from sham-operated and banded mice treated with siGFP or siMEF2C are shown in Figure 5A-F. Left ventricular fibrosis was attenuated in aortic-banded mice treated with siMEF2C (Figure 5G). Figure 5H displays data of ANP (Atrial Natriuretic Peptide) transcript in the left ventricle from sham-operated and aortic banded mice treated with siGFP or siMEF2C. MEF2C silencing markedly attenuated the rises of ANP transcripts in the left ventricle of banded mice.
###end p 33
###begin title 34
MEF2C silencing prevents the myocardial deleterious effects of pressure overload.
###end title 34
###begin p 35
###xml 106 109 106 109 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(A)</bold>
###xml 123 126 123 126 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(B)</bold>
###xml 142 145 142 145 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(C)</bold>
###xml 171 174 171 174 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(D)</bold>
###xml 198 201 198 201 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(E)</bold>
###xml 228 231 228 231 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(F)</bold>
###xml 256 259 256 259 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(G)</bold>
###xml 355 358 355 358 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(H)</bold>
###xml 33 37 <span type="species:ncbi:10090">mice</span>
###xml 334 338 <span type="species:ncbi:10090">mice</span>
###xml 407 411 <span type="species:ncbi:10090">mice</span>
###xml 464 468 <span type="species:ncbi:10090">mice</span>
###xml 519 523 <span type="species:ncbi:10090">mice</span>
###xml 578 582 <span type="species:ncbi:10090">mice</span>
Myocardial samples of SO and TAC mice treated with siMEF2C or siGFP stained with Masson trichrome (X400): (A) - SO- siGFP, (B) - SO- siMEF2C, (C) - TAC(7days)- SO- siGFP, (D) - TAC(7days)- siMEF2C, (E) - TAC(15days)- SO- siGFP, (F) - TAC(15days)- siMEF2C. (G) Bar graph indicates the average fraction volume of collagen (CVF%) (n = 9 mice each subgroup). (H) Relative quantity (RQ) of ANP transcript (n = 9 mice each subgroup). * p<0.05 compared with values of SO mice; # p<0.05 compared with values of TAC 7days siGFP mice, dagger p<0,05 compared to values of TAC 15days siGFP mice.
###end p 35
###begin title 36
MEF2C Depletion Is Associated with Deficiency in Load-Induced mtDNA Content
###end title 36
###begin p 37
###xml 121 125 121 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Czubryt1">[20]</xref>
###xml 236 240 236 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Attardi1">[21]</xref>
###xml 779 788 779 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008472-g006">Figure 6A</xref>
###xml 495 499 <span type="species:ncbi:10090">mice</span>
###xml 618 622 <span type="species:ncbi:10090">mice</span>
###xml 761 765 <span type="species:ncbi:10090">mice</span>
MEF2 factors are important regulators of gene transcription involved in cardiac mitochondriogenesis and energy metabolism[20]. Mitochondrial proliferation is frequently accompanied by a high rate of mtDNA (mitochondrial DNA) replication[21]. Conceivably, depletion of MEF2C results in changes in the abundance of mtDNA and energy metabolism in overloaded left ventricle. Therefore, we next examined if depletion of MEF2C influences the rises of mtDNA copy number induced by pressure overload in mice left ventricle. The levels of mtDNA relative to nDNA (mtDNA:nDNA) were similar in the left ventricle of sham-operated mice treated with siMEF2C or siGFP. Thus, the data of these two groups were averaged for the comparative analysis with data from aortic banded mice. As shown in Figure 6A, pressure overload lasting for 7 and 15 days markedly increased the left ventricular mtDNA:nDNA ratio. Depletion of MEF2C markedly attenuated the rises of the mtDNA:nDNA ratio induced by aortic banding.
###end p 37
###begin title 38
MEF2C silencing negatively regulates myocardial mitochondriogenesis.
###end title 38
###begin p 39
###xml 0 3 0 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(A)</bold>
###xml 96 99 96 99 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(B)</bold>
###xml 131 134 127 130 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(C)</bold>
###xml 200 203 196 199 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(D)</bold>
###xml 321 325 <span type="species:ncbi:10090">mice</span>
###xml 363 367 <span type="species:ncbi:10090">mice</span>
###xml 419 423 <span type="species:ncbi:10090">mice</span>
###xml 485 489 <span type="species:ncbi:10090">mice</span>
###xml 540 544 <span type="species:ncbi:10090">mice</span>
###xml 601 605 <span type="species:ncbi:10090">mice</span>
(A) Bar graph shows relative quantity (RQ) of mtDNA (mt - mitochondrial) to nDNA (n - nuclear). (B) PGC-1alpha protein expression. (C) Representative chromatogram of AMP, ADP and ATP detection peaks. (D) Bar graph indicates the average values of the AMP:ATP ratio. The data were from left ventricle of SO and TAC (1 day) mice treated with siMEF2C or siGFP (n = 9 mice each subgroup).* p<0.05 compared with values of SO mice; double dagger p<0.05 compared with values of TAC 1day siGFP mice; # p<0.05 compared with values of TAC 7days siGFP mice; dagger p<0.05 compared with values of TAC 15days siGFP mice.
###end p 39
###begin p 40
###xml 319 323 319 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Lehman1">[22]</xref>
###xml 325 329 325 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Russell1">[23]</xref>
###xml 459 468 455 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008472-g006">Figure 6B</xref>
###xml 426 430 <span type="species:ncbi:10090">mice</span>
###xml 693 697 <span type="species:ncbi:10090">mice</span>
The augmentation of mtDNA abundance during the myocardial hypertrophic growth involves regulation of mtDNA replication by mtTFA (mitochondrial transcription factor A) by nuclear-encoded transcription factors (NRFs) and PGC-1 (peroxisome proliferator-activated receptor-gamma coactivator-1) transcriptional co-activators[22], [23]. Therefore, we next examined if depletion of MEF2C could change the expression of PGC-1alpha in mice left ventricle. As shown in Figure 6B, aortic constriction (1 day) induced a rapid increase in the expression of PGC-1alpha, an effect that was markedly attenuated by MEF2C depletion. Basal myocardial expression of PGC-1alpha remained unchanged in sham-operated mice depleted of MEF2C.
###end p 40
###begin p 41
###xml 253 262 253 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008472-g006">Figure 6C</xref>
###xml 555 564 555 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008472-g006">Figure 6D</xref>
###xml 743 752 743 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008472-g006">Figure 6D</xref>
###xml 452 456 <span type="species:ncbi:10090">mice</span>
###xml 492 496 <span type="species:ncbi:10090">mice</span>
###xml 674 678 <span type="species:ncbi:10090">mice</span>
###xml 909 913 <span type="species:ncbi:10090">mice</span>
Given that mitochondria are the major source of energy in the myocardium, we next examined whether changes in the levels of mtDNA:nDNA were accompanied by changes in the myocardial AMP:ATP ratio, as a mean to assess the energy levels of the myocardium. Figure 6C shows a representative chromatogram used for the detection of ATP, ADP and AMP levels of left ventricle. MEF2C silencing did not change AMP:ATP ratio in the left ventricle of sham operated mice, therefore data from sham-operated mice treated with siGFP and siMEF2C were averaged. As shown in Figure 6D, the values of myocardial AMP:ATP ratio were found to be greater in the left ventricle of 1 and 7 day banded mice treated with siMEF2C in comparison to those treated with siGFP (Figure 6D). Overall, these data support the notion that depletion of MEF2C attenuates the load-induced replication of mtDNA and likely in mitochondrial biogenesis in mice left ventricle, associated to a defect in the regulation of PGC-1alpha expression.
###end p 41
###begin title 42
MEF2C Depletion Attenuates Hypertrophy by Modulating mTOR/S6K Pathway
###end title 42
###begin p 43
###xml 192 196 192 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Sarbassov1">[24]</xref>
###xml 198 202 198 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Wullschleger1">[25]</xref>
###xml 379 388 379 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008472-g007">Figure 7A</xref>
###xml 684 688 684 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Hara1">[26]</xref>
###xml 690 694 690 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Kim2">[27]</xref>
###xml 994 1000 994 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008472-g007">Fig 7B</xref>
###xml 1197 1203 1193 1199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008472-g007">Fig 7C</xref>
###xml 1376 1388 1372 1384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008472-g007">Figure 7D, E</xref>
###xml 467 471 <span type="species:ncbi:10090">mice</span>
###xml 958 962 <span type="species:ncbi:10090">mice</span>
###xml 1094 1098 <span type="species:ncbi:10090">mice</span>
Previous studies have indicated that perturbing mitochondrial function can influence the activity of mTOR/S6 kinase, a signaling pathway critically involved in the reactive cardiac hypertrophy[24], [25]. Therefore we next examined whether the anti-hypertrophic effect of MEF2C depletion is related to a defective activation of mTOR (mammalian Target of Rapamycin). Data shown in Figure 7A indicate that aortic banding markedly increased S6K Thr389 phosphorylation in mice left ventricle, while depletion of MEF2C abolished this effect. The amino acid leucine is a potent activator of mTOR complex by a pathway distinct from TSC-2 (Tuberous Sclerosis Protein-2) complex phosphorylation[26], [27]. Thus, we reasoned that supplementation with leucine might rescue the defective activation of mTOR/S6K complex after depletion of MEF2C. Supplementation of leucine in the drinking water enhanced basal phosphorylation of S6K in the left ventricle of sham-operated mice treated with siMEF2C or siGFP (Fig 7B). Moreover, it partially restored the phosphorylation of S6K in the left ventricle of banded mice depleted of MEF2C, in parallel with the restoration of the load-induced expression of PGC-1alpha (Fig 7C). Finally, we found that supplementation with leucine attenuated the anti-hypertrophic effect of MEF2C depletion, as indicated by gravimetry and histological data shown in Figure 7D, E. These data are consistent with the hypothesis that a defect in the activation of mTOR/S6K pathway provides a mechanism by which MEF2C depletion attenuates the load-induced left ventricular hypertrophy.
###end p 43
###begin title 44
MEF2C depletion attenuates hypertrophy by modulating mTOR/S6K pathway.
###end title 44
###begin p 45
###xml 0 3 0 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(A)</bold>
###xml 300 303 300 303 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(B)</bold>
###xml 332 335 332 335 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(C)</bold>
###xml 363 366 359 362 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(D)</bold>
###xml 416 419 412 415 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(E)</bold>
###xml 94 98 <span type="species:ncbi:10090">mice</span>
###xml 136 140 <span type="species:ncbi:10090">mice</span>
###xml 211 215 <span type="species:ncbi:10090">mice</span>
###xml 265 269 <span type="species:ncbi:10090">mice</span>
###xml 407 411 <span type="species:ncbi:10090">mice</span>
###xml 504 508 <span type="species:ncbi:10090">mice</span>
(A) S6K and phosphoS6K (p-S6K) protein expression in the left ventricle of SO and TAC (1 day) mice treated with siMEF2C or siGFP (n = 6 mice each subgroup). From samples of left ventricle of SO and TAC (7 days) mice treated with siMEF2C or siGFP and leucine (n = 9 mice each subgroup) were measured: (B) S6K, phosphoS6K (p-S6K) and (C) PGC-1alpha protein levels, (D) the left ventricle mass/body mass ratio mice and (E) the average fraction volume of collagen (CVF%). * p<0.05 compared with values of SO mice.
###end p 45
###begin title 46
Discussion
###end title 46
###begin p 47
###xml 205 209 <span type="species:ncbi:10090">mice</span>
In this study, we applied RNA interference technology to define the function of MEF2C in the adult heart. Our results demonstrate that the depletion of MEF2C by siRNA attenuates the hypertrophic growth of mice left ventricle in response to pressure overload, reduces hypertrophy in cardiomyocytes and diminishes interstitial fibrosis and attenuates the upregulation of ANP. These effects indicate that the downregulation of pathways controlled by MEF2C mitigates the adverse effects of pathologic cardiac hypertrophy and remodeling. Additionally, the results of the current study reveal that the anti-hypertrophic effects of MEF2C depletion may be related to a defective mobilization of mTOR/S6K by pressure overload, which may be associated with an intricate mechanism that involves negative modulation of the mtDNA replication and changes in myocardial energy metabolism caused by defective activation of PGC-1alpha.
###end p 47
###begin title 48
Myocardial MEF2C Depletion by siRNA
###end title 48
###begin p 49
###xml 1041 1045 1041 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Clemente1">[19]</xref>
###xml 1047 1051 1047 1051 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Zimmermann1">[28]</xref>
###xml 494 498 <span type="species:ncbi:10090">mice</span>
We observed a reduction of about 80% in the levels of myocardial MEF2C through siMEF2C delivery via the jugular vein. The gene silencing induced by siMEF2C was restricted to the lung and heart, indicating the efficiency of this route to achieve delivery of siRNA to the left ventricle, as well as the lack of significant exposure of tissues and organs distal to the left ventricle to siRNA. Besides the left ventricle, depletion of MEF2C was confirmed to occur in cardiomyocytes harvested from mice treated with siMEF2C, thereby demonstrating the susceptibility of this cell type to the effects of systemically delivered siRNA. Moreover, the specificity of MEF2C silencing was substantiated by the lack of effects of siMEF2C on MEF2A, MEF2B or MEF2D, as well as on the unrelated proteins FAK, JNK, SHP2 and GAPDH. The MEF2C depletion induced by the RNAi strategy used in the present study lasted for approximately 4 days. Such a prolonged effect of systemically delivered siRNA was previously observed for distinct targets in various tissues[19], [28], although the underlying mechanism remains unclear.
###end p 49
###begin title 50
Effects of MEF2C Depletion in Overloaded Left Ventricle
###end title 50
###begin p 51
###xml 557 560 557 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Xu1">[8]</xref>
A key finding in the current study is the attenuation of the load-induced left ventricular hypertrophy induced by MEF2C silencing. Remarkably, our results also show that depletion of MEF2C attenuated the interstitial fibrosis and the rise of ANP expression, without affecting the left ventricular function, indicating that depletion of MEF2C may reduce the adverse effects of pressure overload. Consistent with this hypothesis, data from previous studies indicate that activation of MEF2C may mediate myocardial adverse events invoked by pathological stress[8].
###end p 51
###begin p 52
###xml 103 106 103 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Xu1">[8]</xref>
###xml 108 111 108 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-vanOort1">[9]</xref>
###xml 252 256 252 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Lin1">[15]</xref>
###xml 464 467 464 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Xu1">[8]</xref>
###xml 1419 1423 1411 1415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Lehman1">[22]</xref>
###xml 1425 1429 1417 1421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Russell1">[23]</xref>
###xml 1490 1492 1482 1484 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1638 1642 1626 1630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Naya1">[17]</xref>
###xml 1644 1648 1632 1636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Handschin1">[29]</xref>
###xml 1806 1809 1790 1793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Xu1">[8]</xref>
###xml 1811 1815 1795 1799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Lehman1">[22]</xref>
###xml 1817 1821 1801 1805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Russell1">[23]</xref>
###xml 3213 3217 3197 3201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Sebastiani1">[30]</xref>
###xml 3439 3443 3423 3427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-VenturaClapier1">[31]</xref>
###xml 347 362 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1564 1568 <span type="species:ncbi:10090">mice</span>
###xml 2815 2819 <span type="species:ncbi:10090">mice</span>
MEF2 transcription factors have been implicated in the direct and indirect regulation of multiple genes[8], [9]. It has been shown that a null mutation of MEF2C affects the expression of cardiac structural and stress response genes in developing hearts[15]. In addition, studies that analyzed global gene expression in the left ventricle of MEF2C transgenic mice indicated an upregulation of genes encoding ion-handling and extracellular matrix-associated proteins[8], which might be involved in the deleterious effects of MEF2C activation. However, it is still uncertain whether these genes are involved in the hypertrophic growth induced by MEF2C activation. The data gathered in the present study reveal that MEF2C depletion blunted the increases in mtDNA and the ability of the myocardium to sustain the ATP levels when subjected to pressure overload, indicating that MEF2C may play a role in regulating the cardiac mitochondriogenesis and energetic metabolism in response to hypertrophic stimuli. Accordingly, we have shown here that MEF2C depletion markedly attenuated the rise of PGC-1alpha induced by pressure overload, providing an illustration of the specific contribution of the MEF2C to the control of myocardial mitochondria and metabolism in response to mechanical stress. Consistent with this, the level of PGC-1alpha was previously shown to play a major role in setting the cardiac mitochondrial content[22], [23]. Furthermore, MEF2 factors have been shown to mediate the Ca2+/Calcineurin activation of PGC-1alpha promoter and deletion of MEF2A in mice was demonstrated to result in perturbation of mitochondrial structure[17], [29]. Finally, forced expressions of either MEF2C or PGC-1alpha are known to lead to mitochondrial ultrastructural abnormalities and development of cardiomyopathy[8], [22], [23]. Taken together, these data imply that modulation of load-induced mitochondrial biogenesis may contribute to the beneficial effects of MEF2C depletion in overloaded myocardium. It was somewhat surprising to find that the improved cardiac phenotype after MEF2C, i.e. with less fibrosis and less pathological hypertrophy, was accompanied by a transient worse energetic profile including higher AMP/ATP levels. Although we have no clear explanation for these effects, one could speculate they are consistent with an expected increase in the myocardial energy consumption induced by pressure overload in the absence of appropriate hypertrophic growth. Maintenance of normal cardiac function in the face of increased workload but without changes in the left ventricle wall thickness, end-diastolic or end-systolic volumes implies a positive inotropic effect, which is paralleled by increased energy consumption per unit of myocardial mass. This would explain the higher AMP/ATP ratio of overloaded mice left ventricle silenced for MEF2C. Moreover, these data may imply that the activation of mitochondrial biogenesis in the early hypertrophic responses to pressure overload might have detrimental influence on the heart. Accordingly, increased mitochondrial mass could induce abnormally high myocardial oxidative stress that in turn might induce cell loss in the early period of pressure overload[30]. Alternatively, functional and structural abnormalities of mitochondria from overloaded heart might be related solely to increases in mitochondrial mass which might affect myofibrils, compromising the contractile function[31]. Thus it is conceivable that lessening MEF2C levels by modulating the excessive mitochondrial biogenesis of overloaded myocardium, may contribute to mitigate the degeneration of overloaded myocardium. However, this issue needs further studies.
###end p 52
###begin p 53
###xml 119 123 119 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Chan1">[32]</xref>
###xml 125 129 125 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Noga1">[33]</xref>
###xml 129 133 129 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Motoshima1">[34]</xref>
###xml 881 885 881 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Marin1">[18]</xref>
###xml 887 891 887 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Shioi1">[35]</xref>
###xml 1051 1055 1051 1055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Chen1">[36]</xref>
###xml 1535 1539 1535 1539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Chan1">[32]</xref>
###xml 1620 1624 1620 1624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Schieke1">[37]</xref>
###xml 478 482 <span type="species:ncbi:10090">mice</span>
The data from the present study indicate that MEF2C depletion is accompanied by downregulation of the mTOR/S6K pathway [32], [33][34]. Remarkably, the restoration of the activity of this signaling complex after supplementation with leucine was accompanied by suppression of the anti-hypertrophic of MEF2C depletion, indicating that the defective activation of mTOR/S6K pathway is a critical component of the beneficial effects of MEF2C depletion in the cardiac phenotype of TAC mice. Conversely, the activation of this pathway might be involved, together with changes in mitochondrial biogenesis and function, to the detrimental effects of MEF2C activation in cardiac hypertrophy. These assumptions are in agreement with previous data indicating that mTOR/S6K complex plays a crucial role in the hypertrophic growth of cardiomyocytes and left ventricle invoked by mechanical stress[18], [35]. Moreover, mTOR overactivation has been shown to cause increased mitochondrial biogenesis and accumulation of reactive oxygen species in distinct model systems[36], suggesting that the activation of mTOR pathway might be responsible for the detrimental effects of MEF2C activation and vice-versa to the beneficial effects of MEF2C depletion in the mechanically overloaded hearts. However, the mechanisms that connect the MEF2C to mTOR/S6K pathway were not explored in the present study. It is possible that the activation of AMPK induced by the raise in the AMP:ATP relative amount may inhibit the mTOR/S6K complex in the overloaded myocardium[32]. Alternatively, reduced mitochondrial function may also inactivate mTOR activity[37], however further studies are needed to clarify this issue.
###end p 53
###begin p 54
###xml 85 89 <span type="species:ncbi:10090">mice</span>
In conclusion, we used RNAi strategy to deplete MEF2C in the left ventricle of adult mice and understand the role of this factor in the responses of the left ventricle to mechanical stress. The data indicate that depletion of MEF2C is sufficient to markedly attenuate the hypertrophic growth and myocardial fibrosis of overloaded left ventricle by a mechanism dependent on defective activation of mTOR/S6K pathway. Overall, these data highlight the potential of MEF2C in the pathogenesis of cardiac hypertrophy and remodeling, and provide insights into novel therapeutic targets to heart disease.
###end p 54
###begin title 55
Materials and Methods
###end title 55
###begin p 56
###xml 9 30 9 30 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 75 82 75 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008472.s001">Text S1</xref>
Expanded Materials and Methods are available in the Supporting Information Text S1 file of this manuscript.
###end p 56
###begin title 57
Ethics Statement
###end title 57
###begin p 58
Animals were handled in compliance with the principles of laboratory animal care formulated by the Animal Care and Use Committee of University of Campinas. Procedures such as jugular vein catheterization, aortic banding, echocardiographic examination and arterial vessels catheterization for blood pressure monitoring were performed under anesthesia with a mixture of ketamine (100 mg/Kg) and xylazine (5 mg/Kg).
###end p 58
###begin title 59
Antibodies and Chemicals
###end title 59
###begin p 60
###xml 11 16 <span type="species:ncbi:10090">mouse</span>
###xml 81 87 <span type="species:ncbi:9986">rabbit</span>
Polyclonal mouse antibody against MEF2C was from Abcam (ab43796-100). Polyclonal rabbit antibodies against FAK (sc558), SHP2 (sc7384), JNK (sc571), GAPDH (sc25778), S6K p70 (sc230), pS6K p70 Thr389 (sc11759R) and PGC1-alpha (sc13067), were purchased from Santa Cruz Biotechnology (USA). Antibody against MEF2A was from Cell Signaling (9736). Antibodies were used following the manufacturer's recommendation. Colagenase type IA and trypsin were from Sigma (USA). Trizol, Phenol and Super Script II were from Invitrogen. Super Signal west Pico Cheluminescent Substract and Ampliscribe T7 high yield transcription were from Epicentre. L-Leucine was from Ajinomoto Aminoscience LLC.
###end p 60
###begin title 61
Experimental Models and Animals
###end title 61
###begin p 62
###xml 551 555 551 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Clemente1">[19]</xref>
###xml 718 719 718 719 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 754 758 754 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Torsoni1">[38]</xref>
###xml 6 10 <span type="species:ncbi:10090">mice</span>
###xml 39 50 <span type="species:ncbi:10116">Wistar rats</span>
###xml 586 589 <span type="species:ncbi:10116">rat</span>
###xml 654 665 <span type="species:ncbi:10116">Wistar rats</span>
Swiss mice (6-8 week old) and neonatal Wistar rats were obtained from the animal facility center of State University of Campinas. Animals were handled in compliance with the principles of laboratory animal care formulated by the university's Animal Care and Use Committee. Procedures such as jugular vein catheterization, aortic banding, echocardiographic examination and arterial vessels catheterization for blood pressure monitoring were performed under anesthesia with a mixture of ketamine (100 mg/Kg) and xylazine (5 mg/Kg) as previously reported[19]. Primary cultures of neonatal rat ventricular myocytes (NRVMs) were prepared from 1- to 2-day-old Wistar rats and plated on type I collagen Bioflex plates at 5x105 cells/well, as previously reported[38].
###end p 62
###begin title 63
###xml 19 24 <span type="species:ncbi:10090">Mouse</span>
Isolation of Adult Mouse Ventricular Myocytes
###end title 63
###begin p 64
###xml 158 162 158 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Clemente1">[19]</xref>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 42 46 <span type="species:ncbi:10090">mice</span>
Mouse cardiac myocytes were isolated from mice ventricle one day after treatment with siRNA targeted to MEF2C (siMEF2C) or GFP (siGFP), as previously reported[19].
###end p 64
###begin title 65
Echocardiography
###end title 65
###begin p 66
###xml 218 222 218 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Clemente1">[19]</xref>
###xml 120 124 <span type="species:ncbi:10090">mice</span>
2D M-mode echocardiography was performed with a 12-MHz probe connected to a Toshiba Power Vision system in anesthetized mice by a blinded observer at 15 minutes after the induction of anesthesia, as previously reported[19]. The short axis measurements were taken at the level of the midpapillary muscle. Three measurements were taken at end-systole and end-diastole to determine left ventricular diastolic and systolic diameter, wall thickness and fractional shortening.
###end p 66
###begin title 67
Hemodynamics
###end title 67
###begin p 68
For blood pressure monitoring the right carotid and the right femoral arteries were cannulated with flame stretched PE-50 polyethylene tube. Blood pressure in the carotid and femoral arteries were simultaneously recorded for a 10 minute period to determine the transconstriction systolic gradient. The following parameters were computed: systemic systolic, mean and diastolic blood pressure (mmHg) and heart rate (bpm).
###end p 68
###begin title 69
Histological Examination
###end title 69
###begin p 70
###xml 52 56 <span type="species:ncbi:10090">mice</span>
Hearts were rapidly excised from fully anesthetized mice and washed in PBS. The left ventricles were fixed in 10% paraformaldehyde, embedded in paraffin and cut into 5 microm sections. Tissue sections stained with haematoxylin and eosin (HE) and Masson's trichrome underwent morphometric studies using an image analysis system (Leica Q500 iW; Leica Imaging Systems, Cambridge, UK).
###end p 70
###begin title 71
siRNA Design and Synthesis
###end title 71
###begin p 72
###xml 87 91 87 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Marin1">[18]</xref>
###xml 93 97 93 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Clemente1">[19]</xref>
###xml 154 180 154 180 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGTAATACGACTCACTATAG-3&#8242;</named-content>
###xml 206 233 206 233 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCCACCUGGCAGCAAGAACAC-3&#8242;</named-content>
###xml 263 290 263 290 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GUUCUUGCUGCCAGGUGGGAU-3&#8242;</named-content>
###xml 308 352 308 352 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GTGTCTTGTAGTTCCCGTCTATAGTGAGTCGTATTACC-3&#8242;</named-content>
###xml 374 420 374 420 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ATGACGGGAACTACAAACACCTATAGTGAGTCGTATTACC-3&#8242;</named-content>
###xml 18 23 <span type="species:ncbi:10090">mouse</span>
siRNA targeted to mouse MEF2C gene was designed and synthesized as previously published[18], [19]. DNA oligonucleotides (IDT-USA) were as follow: (i) T7: 5'-GGTAATACGACTCACTATAG-3'. (ii): MEF2C 1187 sense: 5'-CCCACCUGGCAGCAAGAACAC-3' (iii): MEF2C 1187 antisense: 5'-GUUCUUGCUGCCAGGUGGGAU-3' (iv): GFP sense: 5'-GTGTCTTGTAGTTCCCGTCTATAGTGAGTCGTATTACC-3'. (v): GFP antisense: 5'-ATGACGGGAACTACAAACACCTATAGTGAGTCGTATTACC-3' were ordered from IDT (USA). The oligonucleotide-directed production of small RNA transcripts with T7 RNA polymerase were made with Ampliscribetrade mark T7 transcription kit (Epicentre Biotechnologies; Madison WI, USA) according to manufacturer's instructions.
###end p 72
###begin title 73
Transfection of NRVMs with siRNA
###end title 73
###begin p 74
###xml 57 61 57 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008472-Marin1">[18]</xref>
NRVMs were transfected with siRNA as previously reported [18].
###end p 74
###begin title 75
Western Blotting
###end title 75
###begin p 76
Tissue or cell extracts containing equal amounts of total protein (50 microg) were resolved by 8% SDS-PAGE. The membranes were incubated with primary antibodies. Detection was accomplished by using an enhanced chemiluminescence detection system.
###end p 76
###begin title 77
Gene Transcripts and Mitochondrial DNA Quantification
###end title 77
###begin p 78
###xml 151 159 151 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008472.s002">Table S1</xref>
Myocardial MEF2A, MEF2C, MEF2D and ANP transcripts were quantified after reverse transcription to cDNA followed by real-time PCR. Primers are shown in Table S1 of Supporting Information. Results were evaluated by the comparative CT method in respect to GAPDH, used as the normalizer. For mithocondrial and nuclear DNA quantification, were compared the expression of D-loop (EU194676.1) and 18S rRNA (NR_003278.1) genes, respectively.
###end p 78
###begin title 79
Myocardial AMP and ATP
###end title 79
###begin p 80
Samples of myocardium were analyzed for AMP and ATP quantification by a method based on high performance liquid chromatography.
###end p 80
###begin title 81
Statistical Analysis
###end title 81
###begin p 82
###xml 45 46 43 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 195 196 193 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Data are presented as means+/-SEM. Student's t-test and 1-way repeated-measures ANOVA were used to compare groups. Post hoc analysis was performed with Bonferroni multiple-range test. A value of P<0.05 indicated statistical significance.
###end p 82
###begin title 83
Supporting Information
###end title 83
###begin p 84
(0.08 MB DOC)
###end p 84
###begin p 85
Click here for additional data file.
###end p 85
###begin p 86
(0.04 MB DOC)
###end p 86
###begin p 87
Click here for additional data file.
###end p 87
###begin title 88
References
###end title 88
###begin article-title 89
The cardiomyopathy of overload: an unnatural growth response in the hypertrophied heart.
###end article-title 89
###begin article-title 90
Controversies in ventricular remodelling.
###end article-title 90
###begin article-title 91
Prognostic implications of left ventricular hypertrophy.
###end article-title 91
###begin article-title 92
Decompensation of cardiac hypertrophy: cellular mechanisms and novel therapeutic targets.
###end article-title 92
###begin article-title 93
Stress pathways and heart failure.
###end article-title 93
###begin article-title 94
Regulation of cardiac hypertrophy by intracellular signalling pathways.
###end article-title 94
###begin article-title 95
The fuzzy logic of physiological cardiac hypertrophy.
###end article-title 95
###begin article-title 96
###xml 68 83 <span type="species:ncbi:10090">transgenic mice</span>
Myocyte enhancer factors 2A and 2C induce dilated cardiomyopathy in transgenic mice.
###end article-title 96
###begin article-title 97
MEF2 activates a genetic program promoting chamber dilation and contractile dysfunction in calcineurin-induced heart failure.
###end article-title 97
###begin article-title 98
###xml 79 83 <span type="species:ncbi:10090">mice</span>
The MEF2D transcription factor mediates stress-dependent cardiac remodeling in mice.
###end article-title 98
###begin article-title 99
Myocyte-specific enhancer-binding factor (MEF-2) regulates alpha-cardiac myosin heavy chain gene expression in vitro and in vivo.
###end article-title 99
###begin article-title 100
###xml 52 55 <span type="species:ncbi:10116">rat</span>
Load-induced transcriptional activation of c-jun in rat myocardium: regulation by myocyte enhancer factor 2.
###end article-title 100
###begin article-title 101
Focal adhesion kinase mediates MEF2 and c-Jun activation by stretch: role in the activation of the cardiac hypertrophic genetic program.
###end article-title 101
###begin article-title 102
###xml 67 72 <span type="species:ncbi:9606">human</span>
Transcriptional genomics associates FOX transcription factors with human heart failure.
###end article-title 102
###begin article-title 103
###xml 11 16 <span type="species:ncbi:10090">mouse</span>
Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C.
###end article-title 103
###begin article-title 104
###xml 36 41 <span type="species:ncbi:10090">mouse</span>
The transcription factor MEF2C-null mouse exhibits complex vascular malformations and reduced cardiac expression of angiopoietin 1 and VEGF.
###end article-title 104
###begin article-title 105
###xml 53 57 <span type="species:ncbi:10090">mice</span>
Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factor.
###end article-title 105
###begin article-title 106
Shp2 negatively regulates growth in cardiomyocytes by controlling focal adhesion kinase/Src and mTOR pathways.
###end article-title 106
###begin article-title 107
###xml 117 121 <span type="species:ncbi:10090">mice</span>
Targeting focal adhesion kinase with small interfering RNA prevents and reverses load-induced cardiac hypertrophy in mice.
###end article-title 107
###begin article-title 108
Balancing contractility and energy production: the role of myocyte enhancer factor 2 (MEF2) in cardiac hypertrophy.
###end article-title 108
###begin article-title 109
Biogenesis of mitochondria.
###end article-title 109
###begin article-title 110
Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis.
###end article-title 110
###begin article-title 111
Cardiac-specific induction of the transcriptional coactivator peroxisome proliferator-activated receptor gamma coactivator-1alpha promotes mitochondrial biogenesis and reversible cardiomyopathy in a developmental stage-dependent manner.
###end article-title 111
###begin article-title 112
Growing roles for the mTOR pathway.
###end article-title 112
###begin article-title 113
TOR signaling in growth and metabolism.
###end article-title 113
###begin article-title 114
Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism.
###end article-title 114
###begin article-title 115
Regulation of TORC1 by Rag GTPases in nutrient response.
###end article-title 115
###begin article-title 116
###xml 36 41 <span type="species:ncbi:9606">human</span>
RNAi-mediated gene silencing in non-human primates.
###end article-title 116
###begin article-title 117
An autoregulatory loop controls peroxisome proliferator-activated receptor gamma coactivator 1alpha expression in muscle.
###end article-title 117
###begin article-title 118
Induction of mitochondrial biogenesis is a maladaptive mechanism in mitochondrial cardiomyopathies.
###end article-title 118
###begin article-title 119
Transcriptional control of mitochondrial biogenesis: the central role of PGC-1alpha.
###end article-title 119
###begin article-title 120
Activation of AMP-activated protein kinase inhibits protein synthesis associated with hypertrophy in the cardiac myocyte.
###end article-title 120
###begin article-title 121
Expression of an active LKB1 complex in cardiac myocytes results in decreased protein synthesis associated with phenylephrine-induced hypertrophy.
###end article-title 121
###begin article-title 122
AMPK and cell proliferation-AMPK as a therapeutic target for atherosclerosis and cancer.
###end article-title 122
###begin article-title 123
###xml 57 61 <span type="species:ncbi:10090">mice</span>
Rapamycin attenuates load-induced cardiac hypertrophy in mice.
###end article-title 123
###begin article-title 124
TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species.
###end article-title 124
###begin article-title 125
The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidative capacity.
###end article-title 125
###begin article-title 126
Focal adhesion kinase is activated and mediates the early hypertrophic response to stretch in cardiac myocytes.
###end article-title 126
###begin p 127
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 127
###begin p 128
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: Funding for this work was provided by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) grants 2006/54878-3, 2008/53583-5, 2008/53519-5, Conselho Nacional de Desenvolvimento Cienti-fico e Tecnologico (CNPq) grants 305604/2006-6, 501160/2008-6 and Laboratorio Cristalia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 128

